Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Giorgio Tettamanti, Rickard Ljung, Anders Ahlbom, Mats Talbäck, Birgitta Lannering, Tiit Mathiesen, Jenny Pettersson Segerlind & Maria Feychting. (2019) Central nervous system tumor registration in the Swedish Cancer Register and Inpatient Register between 1990 and 2014. Clinical Epidemiology 11, pages 81-92.
Read now
Read now
Shuji Suzuki, Mitsugi Shimoda, Jiro Shimazaki, Tsunehiko Maruyama, Yukio Oshiro, Kiyotaka Nishida, Jun Kuroda, Kenta Miyoshi, Nobusada Koike & Nobuhiko Harada. (2019) Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma. Clinical and Experimental Gastroenterology 12, pages 255-262.
Read now
Read now
Shao-Bin Huang & Chao-Xu Zheng. (2017) Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma. Expert Review of Anticancer Therapy 17:1, pages 89-96.
Read now
Read now
Richard A. Burkhart, Daniel A. Laheru, Joseph M. Herman & Timothy M. Pawlik. (2016) Multidisciplinary management and the future of treatment in cholangiocarcinoma. Expert Opinion on Orphan Drugs 4:3, pages 255-267.
Read now
Read now
Carl Kilander, Fredrik Mattsson, Rickard Ljung, Jesper Lagergren & Omid Sadr-Azodi. (2014) Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncologica 53:6, pages 822-829.
Read now
Read now
. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:9, pages 1027-1028.
Read now
Read now
Articles from other publishers (79)
Olanrewaju A. Eletta, Guergana G. Panayotova & Keri E. Lunsford. (2024) Liver Transplant for Intrahepatic Cholangiocarcinoma. Surgical Clinics of North America 104:1, pages 215-225.
Crossref
Crossref
Xiwei Ding, Kais Zakharia, Catherine D. Moser, Nellie A. Campbell, Chunling Hu, Nataliya Razumilava, Roongruedee Chaiteerakij, Hassan M. Shaleh, Patricia T. Greipp, Rondell P. Graham, Xiaoping Zou, Vishal S. Chandan & Lewis R. Roberts. (2022) Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. Cancers 14:20, pages 5080.
Crossref
Crossref
Md Ataul Islam, Mayuri Makarand Barshetty, Sridhar Srinivasan, Dawood Babu Dudekula, V. P. Subramanyam Rallabandi, Sameer Mohammed, Sathishkumar Natarajan & Junhyung Park. (2022) Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study. Biomolecules 12:9, pages 1279.
Crossref
Crossref
Gonzalo Sapisochin, Tommy Ivanics & Julie Heimbach. (2022) Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?. Hepatology 75:2, pages 455-472.
Crossref
Crossref
Maria A. Gonzalez-Carmona, Christian Möhring, Robert Mahn, Taotao Zhou, Alexandra Bartels, Farsaneh Sadeghlar, Maximilian Bolch, Annabelle Vogt, Dominik J. Kaczmarek, Dominik J. Heling, Leona Dold, Jacob Nattermann, Vittorio Branchi, Hanno Matthaei, Steffen Manekeller, Jörg C. Kalff, Christian P. Strassburg, Raphael U. Mohr & Tobias J. Weismüller. (2022) Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy. Scientific Reports 12:1.
Crossref
Crossref
Gabriel Allo, Ahu Can, Roger Wahba, Nils Vogel, Tobias Goeser, Fabian Kütting & Dirk Waldschmidt. (2021) Nanoliposomal irinotecan in combination with leucovorin and 5‑fluorouracil in advanced biliary tract cancers. Molecular and Clinical Oncology 16:2.
Crossref
Crossref
Zeyuan Qiang, Haofeng Zhang, Shuai Jin, Cao Yan, Zhen Li, Lianyuan Tao & Haibo Yu. (2021) The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection. World Journal of Surgical Oncology 19:1.
Crossref
Crossref
Vladimir Bezrookove, John M. Patino, Mehdi Nosrati, Pierre-Yves Desprez, Sean McAllister, Liliana Soroceanu, Ari Baron, Robert Osorio, Mohammed Kashani-Sabet & Altaf A. Dar. (2021) Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress. Cancers 13:17, pages 4405.
Crossref
Crossref
Sven Arke Lang, Jan Bednarsch, Zoltan Czigany, Katharina Joechle, Andreas Kroh, Iakovos Amygdalos, Pavel Strnad, Tony Bruns, Daniel Heise, Florian Ulmer & Ulf Peter Neumann. (2021) Liver transplantation in malignant disease. World Journal of Clinical Oncology 12:8, pages 623-645.
Crossref
Crossref
Lukas Müller, Aline Mähringer-Kunz, Simon Johannes Gairing, Friedrich Foerster, Arndt Weinmann, Fabian Bartsch, Lisa-Katharina Heuft, Janine Baumgart, Christoph Düber, Felix Hahn & Roman Kloeckner. (2021) Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment. Journal of Clinical Medicine 10:10, pages 2071.
Crossref
Crossref
Zhi Ven Fong, Sarah A. Brownlee, Motaz Qadan & Kenneth K. Tanabe. (2021) The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines. Annals of Surgical Oncology 28:5, pages 2660-2674.
Crossref
Crossref
Tim Reese, Gregor Pagel, Bettina A. Bause, York von Rittberg, Kim C. Wagner & Karl J. Oldhafer. (2021) Complex Liver Resections for Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine 10:8, pages 1672.
Crossref
Crossref
Tadashi Toyohara, Takahiro Nakazawa, Kais Zakharia, Shuya Shimizu, Katsuyuki Miyabe, Kenichi Harada, Kenji Notohara, Tomohiro Yamada, Katsumi Hayashi, Itaru Naitoh, Kazuki Hayashi & Hiromi Kataoka. (2021) IgG4-related Sclerosing Cholangitis Complicated with Cholangiocarcinoma and Detected by Forkhead Box P3 Immunohistochemical Staining. Internal Medicine 60:6, pages 859-866.
Crossref
Crossref
Dan Wang, Zhouyu Ning, Zhenfeng Zhu, Chenyue Zhang, Peng Wang & Zhiqiang Meng. (2021) LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway. The International Journal of Biochemistry & Cell Biology 132, pages 105845.
Crossref
Crossref
Tobias J. Weismüller. (2021) Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma. Visceral Medicine 37:1, pages 39-47.
Crossref
Crossref
Felix Hahn, Lukas Müller, Aline Mähringer-Kunz, Yasemin Tanyildizi, Daniel Pinto dos Santos, Christoph Düber, Peter R. Galle, Arndt Weinmann & Roman Kloeckner. (2020) Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients. Journal of Oncology 2020, pages 1-8.
Crossref
Crossref
Raphael Mohr, Burcin Özdirik, Jana Knorr, Alexander Wree, Münevver Demir, Frank Tacke & Christoph Roderburg. (2020) In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?. International Journal of Molecular Sciences 21:14, pages 4993.
Crossref
Crossref
Felix Hahn, Lukas Müller, Florian Jungmann, Aline Mähringer-Kunz, Yasemin Tanyildizi, Christoph Düber, Peter R. Galle, Arndt Weinmann & Roman Kloeckner. (2020) Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging. Journal of Cancer Research and Clinical Oncology 146:7, pages 1883-1890.
Crossref
Crossref
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn & Jessica L. Petrick. (2020) Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 126:11, pages 2666-2678.
Crossref
Crossref
Felix Hahn, Lukas Müller, Aline Mähringer-Kunz, Sebastian Schotten, Christoph Düber, Jan B. Hinrichs, Sabine K. Maschke, Peter R. Galle, Fabian Bartsch, Hauke Lang, Arndt Weinmann & Roman Kloeckner. (2020) Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system. PLOS ONE 15:2, pages e0228501.
Crossref
Crossref
Vincenzo Mazzaferro, Andre Gorgen, Sasan Roayaie, Michele Droz dit Busset & Gonzalo Sapisochin. (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. Journal of Hepatology 72:2, pages 364-377.
Crossref
Crossref
Natascha Roehlen, Armando Andres Roca Suarez, Houssein El Saghire, Antonio Saviano, Catherine Schuster, Joachim Lupberger & Thomas F. Baumert. (2020) Tight Junction Proteins and the Biology of Hepatobiliary Disease. International Journal of Molecular Sciences 21:3, pages 825.
Crossref
Crossref
L. Perkhofer, A. W. Berger, A. K. Beutel, E. Gallmeier, S. Angermeier, L. Fischer von Weikersthal, T. O. Goetze, R. Muche, T. Seufferlein & T. J. Ettrich. (2019) Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study. BMC Cancer 19:1.
Crossref
Crossref
Vikas Bhuria, Jun Xing, Tim Scholta, Khac Cuong Bui, Mai Ly Thi Nguyen, Nisar P. Malek, Przemyslaw Bozko & Ruben R. Plentz. (2019) Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma. Experimental Cell Research 385:2, pages 111671.
Crossref
Crossref
Kazuyuki Ishida, Mitsumasa Osakabe, Makoto Eizuka, Seigo Tai, Ryo Sugimoto, Yasuko Fujita, Hirokatsu Katagiri, Takeshi Takahara, Noriyuki Uesugi, Hiroyuki Nitta, Akira Sasaki & Tamotsu Sugai. (2019) The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location. Human Pathology 92, pages 91-100.
Crossref
Crossref
T. J. Ettrich, D. Schwerdel, A. Dolnik, F. Beuter, T. J. Blätte, S. A. Schmidt, N. Stanescu-Siegmund, J. Steinacker, R. Marienfeld, A. Kleger, L. Bullinger, T. Seufferlein & A. W. Berger. (2019) Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information. Scientific Reports 9:1.
Crossref
Crossref
Felix Hahn, Lukas Müller, Fabian Stöhr, Aline Mähringer‐Kunz, Sebastian Schotten, Christoph Düber, Fabian Bartsch, Hauke Lang, Peter R Galle, Arndt Weinmann & Roman Kloeckner. (2019) The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?. Liver International 39:7, pages 1307-1314.
Crossref
Crossref
René Günther Feichtinger, Daniel Neureiter, Ralf Kemmerling, Johannes Adalbert Mayr, Tobias Kiesslich & Barbara Kofler. (2019) Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma. Cells 8:6, pages 539.
Crossref
Crossref
Nora Schweitzer, Martha M. Kirstein, Anna‐Maria Kratzel, Young‐Seon Mederacke, Mareike Fischer, Michael P. Manns & Arndt Vogel. (2019) Second‐line chemotherapy in biliary tract cancer: Outcome and prognostic factors. Liver International 39:5, pages 914-923.
Crossref
Crossref
Thomas von Hahn, K. I. Ringe & A. Potthoff. (2019) Erkrankungen und Diagnostik der GallenwegeDiseases and diagnosis of the biliary system. Der Radiologe 59:4, pages 293-299.
Crossref
Crossref
Dirk Walter, Philip Ferstl, Oliver Waidmann, Jörg Trojan, Sylvia Hartmann, Andreas A. Schnitzbauer, Stefan Zeuzem & Klaus Kraywinkel. (2018) Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification. Liver International 39:2, pages 316-323.
Crossref
Crossref
Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott & Sharon M. Weber. 2019. Intrahepatic Cholangiocarcinoma. Intrahepatic Cholangiocarcinoma
11
20
.
G. Lurje, J. Bednarsch, C. Roderburg, C. Trautwein & U. P. Neumann. (2018) Aktueller Therapiealgorithmus des intrahepatischen cholangiozellulären KarzinomsIntrahepatic cholangiocarcinoma – current perspectives and treatment algorithm. Der Chirurg 89:11, pages 858-864.
Crossref
Crossref
H. P. Neeff, P. A. Holzner, M. Menzel, P. Bronsert, A. Klock, S. A. Lang, S. Fichtner-Feigl, U. T. Hopt & F. Makowiec. (2018) Das intrahepatische CholangiokarzinomIntrahepatic cholangiocarcinoma. Der Chirurg 89:5, pages 374-380.
Crossref
Crossref
Jae Seung Kang, Seungyeoun Lee, Donghee Son, Youngmin Han, Kyung Bun Lee, Jae Ri Kim, Wooil Kwon, Sun-Whe Kim & Jin-Young Jang. (2018) Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system. Journal of Hepato-Biliary-Pancreatic Sciences 25:2, pages 124-130.
Crossref
Crossref
Yuyao Yin, Mingming Zhang, Robert Gregory Dorfman, Yang Li, Zhenguo Zhao, Yida Pan, Qian Zhou, Shan Huang, Shimin Zhao, Yuling Yao & Xiaoping Zou. (2017) Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition. Cell Death & Disease 8:6, pages e2856-e2856.
Crossref
Crossref
Avik Majumdar, Davide Roccarina, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2017) Management of people with early- or very early-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2017) Management of people with intermediate-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Boris Blechacz. (2017) Cholangiocarcinoma: Current Knowledge and New Developments. Gut and Liver 11:1, pages 13-26.
Crossref
Crossref
Svenja Sydor, Sami Jafoui, Lena Wingerter, Sandra Swoboda, Joachim C Mertens, Guido Gerken, Ali Canbay, Andreas Paul & Christian D Fingas. (2017) Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells. World Journal of Gastroenterology 23:22, pages 4007.
Crossref
Crossref
Arndt Vogel & Anna Saborowski. (2017) Cholangiocellular Carcinoma. Digestion 95:3, pages 181-185.
Crossref
Crossref
S. Lindsey Davis. 2017. Radiation Therapy for Liver Tumors. Radiation Therapy for Liver Tumors
201
221
.
Yong Li, Dajiang Li, Jian Chen & Shuguang Wang. (2016) A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67 kDa Laminin Receptor (LR). International Journal of Biological Macromolecules 93, pages 520-525.
Crossref
Crossref
Thomas C. Wirth & Arndt Vogel. (2016) Surveillance in cholangiocellular carcinoma. Best Practice & Research Clinical Gastroenterology 30:6, pages 987-999.
Crossref
Crossref
Samarpita Barat, Przemyslaw Bozko, Xi Chen, Tim Scholta, Franziska Hanert, Julian Götze, Nisar P. Malek, Ludwig Wilkens & Ruben R. Plentz. (2016) Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma. Molecular Carcinogenesis 55:12, pages 2037-2050.
Crossref
Crossref
Yu Wang, Xiwei Ding, Shaoqing Wang, Catherine D. Moser, Hassan M. Shaleh, Essa A. Mohamed, Roongruedee Chaiteerakij, Loretta K. Allotey, Gang Chen, Katsuyuki Miyabe, Melissa S. McNulty, Albert Ndzengue, Emily G. Barr Fritcher, Ryan A. Knudson, Patricia T. Greipp, Karl J. Clark, Michael S. Torbenson, Benjamin R. Kipp, Jie Zhou, Michael T. Barrett, Michael P. Gustafson, Steven R. Alberts, Mitesh J. Borad & Lewis R. Roberts. (2016) Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. Cancer Letters 380:1, pages 163-173.
Crossref
Crossref
ALENA MÜLLER, SAMARPITA BARAT, XI CHEN, KHAC CUONG BUI, PRZEMYSLAW BOZKO, NISAR P. MALEK & RUBEN R. PLENTZ. (2016) Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. International Journal of Oncology 48:5, pages 2025-2034.
Crossref
Crossref
John A. BridgewaterKaryn A. GoodmanAparna KalyanMary F. Mulcahy. (2016) Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling. American Society of Clinical Oncology Educational Book:36, pages e194-e203.
Crossref
Crossref
Lian Li, Hui-Jun Guo, Ling-Yan Zhu, Limin Zheng & Xin Liu. (2016) A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial–mesenchymal transition. Phytomedicine 23:5, pages 491-497.
Crossref
Crossref
Xiwei Ding, Roongruedee Chaiteerakij, Catherine D. Moser, Hassan Shaleh, Jeffrey Boakye, Gang Chen, Albert Ndzengue, Ying Li, Yanling Zhou, Shengbing Huang, Frank A. Sinicrope, Xiaoping Zou, Melanie B. Thomas, Charles D. Smith & Lewis R. Roberts. (2016) Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. Oncotarget 7:15, pages 20080-20092.
Crossref
Crossref
Ruben R. Plentz & Nisar P. Malek. (2016) Systemic Therapy of Cholangiocarcinoma. Visceral Medicine 32:6, pages 427-430.
Crossref
Crossref
Martha M. Kirstein & Arndt Vogel. (2016) Epidemiology and Risk Factors of Cholangiocarcinoma. Visceral Medicine 32:6, pages 395-400.
Crossref
Crossref
Jason Ho & Steven A. Curley. 2016. Gastrointestinal Malignancies. Gastrointestinal Malignancies
121
163
.
Seung Tae Kim, Maruja Lira, Shibing Deng, Sujin Lee, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Mao Mao, Jin Seok Heo, Wooil Kwon, Kee‑Taek Jang, Jeeyun Lee & Joon Oh Park. (2015) PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA. Oncotarget 6:37, pages 40026-40035.
Crossref
Crossref
R.R. Plentz & A. Vogel. (2015) Therapie des metastasierten CholangiokarzinomsTherapy of metastasized cholangiocarcinoma. Der Onkologe 21:11, pages 1064-1068.
Crossref
Crossref
Majid A. Almadi, Jeffrey S. Barkun & Alan N. Barkun. (2015) Stenting in Malignant Biliary Obstruction. Gastrointestinal Endoscopy Clinics of North America 25:4, pages 691-711.
Crossref
Crossref
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn & Brian R Davidson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn & Brian R Davidson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Annika Bergquist & Erik von Seth. (2015) Epidemiology of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 29:2, pages 221-232.
Crossref
Crossref
Jesper B. Andersen. (2015) Molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 22:2, pages 101-113.
Crossref
Crossref
JUNJI MA, JUNLI SHI, DONGQIANG ZHAO, LIJUAN CHENG, WENBIN WANG, FANGFANG LI, XIAOYU JIANG & HUIQING JIANG. (2015) Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression. Oncology Letters 9:1, pages 15-24.
Crossref
Crossref
Jens U Marquardt & Jesper B Andersen. (2015) Liver cancer oncogenomics: opportunities and dilemmas for clinical applications. Hepatic Oncology 2:1, pages 79-93.
Crossref
Crossref
Kelly J. Lafaro, David Cosgrove, Jean-Francois H. Geschwind, Ihab Kamel, Joseph M. Herman & Timothy M. Pawlik. (2015) Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterology Research and Practice 2015, pages 1-14.
Crossref
Crossref
Xiwei Ding, Bin Zhang, Qingshan Pei, Jianmei Pan, Shuling Huang, Yan Yang, Zhu Zhu, Ying Lv & Xiaoping Zou. (2014) Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1. BMC Cancer 14:1.
Crossref
Crossref
Matthias Pinter, Florian Hucke, Nadine Zielonke, Thomas Waldhör, Michael Trauner, Markus Peck-Radosavljevic & Wolfgang Sieghart. (2014) Incidence and mortality trends for biliary tract cancers in Austria. Liver International 34:7, pages 1102-1108.
Crossref
Crossref
Julie Konfortion, Victoria H. Coupland, Hemant M. Kocher, William Allum, Melanie J. Grocock & Ruth H. Jack. (2014) Time and deprivation trends in incidence of primary liver cancer subtypes in England. Journal of Evaluation in Clinical Practice 20:4, pages 498-504.
Crossref
Crossref
Ugo Fedeli, Francesco Avossa, Stefano Guzzinati, Emanuela Bovo & Mario Saugo. (2014) Trends in mortality from chronic liver disease. Annals of Epidemiology 24:7, pages 522-526.
Crossref
Crossref
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik & Gregory J. Gores. (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology 60:6, pages 1268-1289.
Crossref
Crossref
Annika Wutka, Vindhya Palagani, Samarpita Barat, Xi Chen, Mona El Khatib, Julian Götze, Hanane Belahmer, Steffen Zender, Przemyslaw Bozko, Nisar P. Malek & Ruben R. Plentz. (2014) Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis. PLoS ONE 9:4, pages e95605.
Crossref
Crossref
Guo-wei Zhang, Jian-hua Lin, Jian-ping Qian & Jie Zhou. (2014) Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 109:5, pages 494-499.
Crossref
Crossref
Tushar Patel. (2013) New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Gastroenterology 49:2, pages 165-172.
Crossref
Crossref
G. Rubovszky, I. Láng, E. Ganofszky, Z. Horváth, É. Juhos, T. Nagy, E. Szabó, Z. Szentirmay, B. Budai & E. Hitre. (2013) Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study. European Journal of Cancer 49:18, pages 3806-3812.
Crossref
Crossref
Mona El Khatib, Przemyslaw Bozko, Vindhya Palagani, Nisar P. Malek, Ludwig Wilkens & Ruben R. Plentz. (2013) Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo. PLoS ONE 8:10, pages e77433.
Crossref
Crossref
Kulthida Vaeteewoottacharn, Ryusho Kariya, Kouki Matsuda, Manabu Taura, Chaisiri Wongkham, Sopit Wongkham & Seiji Okada. (2013) Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology 139:9, pages 1551-1562.
Crossref
Crossref
P. Bertuccio, C. Bosetti, F. Levi, A. Decarli, E. Negri & C. La Vecchia. (2013) A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Annals of Oncology 24:6, pages 1667-1674.
Crossref
Crossref
Steffen Zender, Irina Nickeleit, Torsten Wuestefeld, Inga Sörensen, Daniel Dauch, Przemyslaw Bozko, Mona El-Khatib, Robert Geffers, Hueseyin Bektas, Michael P. Manns, Achim Gossler, Ludwig Wilkens, Ruben Plentz, Lars Zender & Nisar P. Malek. (2013) A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas. Cancer Cell 23:6, pages 784-795.
Crossref
Crossref
Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens & Ruben R. Plentz. (2013)
Inhibition of hedgehog signaling attenuates carcinogenesis
in vitro
and increases necrosis of cholangiocellular carcinoma
. Hepatology 57:3, pages 1035-1045.
Crossref
Crossref
Quanbo Zhou, Yuanfeng Gong, Feng Huang, Qing Lin, Bing Zeng, Zhihua Li & Rufu Chen. (2013) Expression Levels and Significance of Nuclear Factor-κB and Epidermal Growth Factor Receptor in Hepatolithiasis Associated with Intrahepatic Cholangiocarcinoma. Digestive Surgery 30:4-6, pages 309-316.
Crossref
Crossref
Sven Jonas. 2013. Erkrankungen des Pankreas. Erkrankungen des Pankreas
453
459
.